Navigation Links
The American Partnership for Eosinophilic Disorders (APFED) Honors Disney Star Demi Lovato and the Jonas Group's Ned Specktor, as 2009-2010 Honorary Ambassadors of Education
Date:5/5/2009

- Two honored because of kindness, support and commitment to education about this rare disease -

- Demi, Ned and Honor Society to attend Premier Gala on Monday, May 11, 2009 at the Mondrian Hotel in Los Angeles -

HOUSTON, May 5 /PRNewswire/ -- In conjunction with National Eosinophil Awareness Week, the American Partnership for Eosinophilic Disorders (APFED) will honor Disney Star Demi Lovato and the Jonas Group's Ned Specktor as 2009-2010 Honorary Ambassadors of Education at its Premier Gala on May 11, 2009 in Los Angeles.

A hugely popular actress and singer, Demi Lovato played 'Mitchie Torres' in the hit Disney Channel Original Movie Camp Rock, and can be currently seen as 'Sonny Monroe' in the well-received Disney Channel Original Series Sonny With A Chance. She will be starring in the upcoming Disney Channel Original Movie Princess Protection Program alongside Selena Gomez. Demi's debut album Don't Forget debuted at #2 on the Billboard 200 in September 2008.

After meeting Sarah Wisely of Pennsylvania who lives with an Eosinophilic Gastrointestinal Disorder (EGID), Demi and Ned Specktor became very interested in educating themselves about the disease and spreading awareness to help other children and adults who suffer with its symptoms. Ned Specktor works with Demi, The Jonas Brothers, Meaghan Martin, Jordin Sparks and the new musical sensation Honor Society.

"Ned and I are honored to be recognized by APFED," said Demi Lovato. "We hope our affiliation with APFED will help expand awareness, diagnosis, education and funding to help find a cure for our friend Sarah and the tens of thousands others suffering with this difficult disease."

Eosinophilic Disorders (EGIDs) are chronic and characterized by a large number of eosinophils (white blood cells) and inflammation in the esophagus (the tube connecting the mouth to the stomach). Symptoms include difficulty swallowing, vomiting, stomach or chest pain, and a failure to thrive. There is no cure and research is ongoing to advance a new treatment option.

"Demi's heart is as big as her smile," said Sarah Wisely, age 16, living with an EGID. "Most people don't understand the struggles of living with an Eosinophilic Disorder because the disease is relatively unknown. I live daily with diarrhea, vomiting, nausea and gain nutrition through a feeding tube, but I always pull myself up to get through the day at school. Demi and Ned have been so great and supportive to me, and very interested in my disease. I am so proud that my Community is recognizing them for their commitment to helping us."

"We were so moved by Demi and Ned's interest and support of Eosinophilic Disorders that we wanted to honor them and show our appreciation of their efforts," said Elizabeth Mays, Founder of APFED. "The need for education and fundraising in EGIDs is very large and growing rapidly in recent years, yet even this smallest gesture of kindness and understanding goes a long way to make a difference in people's lives. We hope the light shined on APFED through Demi and Ned's involvement will help further our reaching our mission around Education, Awareness, Support and Research to find a cure for all living with eosinophilic disorders."

About APFED

The American Partnership for Eosinophilic Disorders (APFED) is a non-profit advocacy organization for those living with eosinophilic esophagitis, eosinophilic gastroenteritis, eosinophilic colitis, hypereosinophilic syndrome, and other eosinophilic disorders. We are a resource for patients, their families, physicians and the medical community.

APFED provides accurate, up-to-date information on eosinophilic disorders and related problems. Our goals are to increase awareness, educate patients and physicians, increase funding for research and provide support for the eosinophilic community. For more information or to make a donation, visit www.apfed.org.

APFED Premier Gala to Honor Demi Lovato and Ned Specktor

Sponsored by Abbott Laboratories, Ception Therapeutics, CSL Behring, and Meritage Pharma, Inc.

Monday, May 11, 2009

6:00 p.m. Cocktails

7:00 p.m. Dinner

9:30 p.m. Awards

Mondrian Hotel/Sky Bar Lounge

8440 Sunset Blvd.

West Hollywood, CA

To purchase a ticket or a table, visit www.apfed.org or call 713-498-8216.


'/>"/>
SOURCE American Partnership for Eosinophilic Disorders
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. American Slide Chart/Perrygraf "SlideGuides" and "SpinGuides" Help Drug Companies Satisfy New PhRMA Guidelines
2. American Oriental Bioengineering To Report First Quarter 2009 Financial Results on May 11, 2009
3. American Psychiatric Foundation Names 2009 Recipients of Awards for Advancing Minority Mental Health
4. Stress Keeps Americans Tossing and Turning
5. ASA May Day - Stung By Exposure of Watergate-like Public Record Deletions, American Society of Anesthesiologists Closes Access to Website Newsletter
6. First-Ever Standardized Scales to Measure the Skins Aging Process Are Introduced at the American Society for Aesthetic Plastic Surgerys Annual Meeting
7. African-American women still have poorer breast cancer outcomes
8. Incisive Surgical to Launch Next Generation More User-Friendly Absorbable Skin Stapler at American College of Obstetricians and Gynecologists
9. Trenton, New Jerseys Boehm Porcelain Art Studio, Preeminent Maker of Fine Porcelain in America, Has Been Saved by a New American Owner-Investor
10. Three-Quarters of Durable Medical Equipment Providers Have Prepared for Pandemic Flu, According to a May 1 Survey by American Association for Homecare
11. Survey finds nearly half of Americans concerned they or their family may get sick from swine flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Linda, CA (PRWEB) , ... May 24, 2016 ... ... fluorescent cell imaging; high content imaging; multiplex immunoassays are widely used for cell ... important for labs to maximize their quality and efficiency in these areas. , ...
(Date:5/23/2016)... ... 23, 2016 , ... On the occasion of his 25th Anniversary of changing ... loss process: , New patients have a consultation and evaluation (done by Dr. Ferdico ... , Body Composition Analysis, There are 15 things that each patient gets checked for, ...
(Date:5/23/2016)... ... 23, 2016 , ... According to an article published May 11th ... birth of her son, Rockwell Lloyd Liu, and notes that gestational surrogacy helped make ... Bill” star explains that, as a career oriented single woman, gestational surrogacy made parenthood ...
(Date:5/23/2016)... ... May 23, 2016 , ... NYDNRehab, a New York City-based ... athletes. This is the first time this type of technology, which was developed by ... to the public in New York. , With over 10 million sport injuries ...
(Date:5/23/2016)... ... May 23, 2016 , ... California State University Northridge ... quality of life and is currently focusing on ways to improve how people ... tested through research to find out whether watching them could have a significant ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... SAN FRANCISCO, Calif. , May 19, 2016 /PRNewswire/ ... a biopharmaceutical company developing novel therapeutics for the treatment ... announced that new GBT440 data will be presented in ... 21 st Congress in Copenhagen ... ongoing Phase 1/2 GBT440-001 study in sickle cell disease ...
(Date:5/19/2016)... 2016 BioLineRx Ltd. (NASDAQ/TASE: BLRX) ... treatment of multiple cancer and hematological indications, will be ... abstract titled " Clinical response in relapsed/refractory AML patients ... BL-8040, a potent CXCR4 antagonist; results of a Phase ... at the European Hematology Association 21st Congress, to be ...
(Date:5/19/2016)... CAMBRIDGE, Massachusetts , May 19, 2016 ... pharmaceuticals and diagnostics based on the gut microbiome, is pleased ... Cambridge, MA to support its operations ... office is located at Kendall Square, the heart of ... global hub for transforming scientific insights into new drugs. The ...
Breaking Medicine Technology: